Form 4: Inspire Medical CFO Sells 11,000 Shares

Inspire Medical Systems' Chief Financial Officer, Richard Buchholz, sold 11,000 shares of common stock for $93.39 per share.

Summary

• Richard Buchholz, Chief Financial Officer of Inspire Medical Systems, Inc. (INSP), reported a sale of common stock.
• The transaction involved the disposition of 11,000 shares of common stock.
• The shares were sold at a price of $93.39 per share.
• The transaction date was August 29, 2025.
• Following this transaction, Richard Buchholz directly beneficially owns 44,867 shares of common stock.
• Additionally, 1,475 shares are indirectly beneficially owned by a daughter, and three separate instances of 1,475 shares are indirectly beneficially owned by sons, totaling 5,900 indirect shares.
• The transaction was made pursuant to a Rule 10b5-1(c) plan, indicating a pre-scheduled sale.

Sentiment

Score: 5

Explanation: The sale of shares by the CFO is a routine insider transaction, explicitly noted as being executed under a Rule 10b5-1 plan. This indicates a pre-scheduled, non-discretionary sale, which typically does not reflect new sentiment about the company's prospects and is therefore considered neutral.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future outlook.

Industry Context

This filing is a routine insider trading disclosure and does not provide information related to broader industry trends or competitors.

Key Dates

Keywords

Inspire Medical Systems, INSP, Richard Buchholz, CFO, Insider Sale, Stock Transaction, Form 4, 10b5-1 Plan